Cargando…
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981698/ https://www.ncbi.nlm.nih.gov/pubmed/35382850 http://dx.doi.org/10.1186/s12967-022-03360-4 |
_version_ | 1784681656413585408 |
---|---|
author | Shenkar, Robert Moore, Thomas Benavides, Christian Lightle, Rhonda Detter, Matthew R. Hobson, Nicholas Girard, Romuald DeBiasse, Dorothy Patrucco, Mary Gallione, Carol Zabramski, Joseph M. Marchuk, Douglas A. Awad, Issam A. |
author_facet | Shenkar, Robert Moore, Thomas Benavides, Christian Lightle, Rhonda Detter, Matthew R. Hobson, Nicholas Girard, Romuald DeBiasse, Dorothy Patrucco, Mary Gallione, Carol Zabramski, Joseph M. Marchuk, Douglas A. Awad, Issam A. |
author_sort | Shenkar, Robert |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8981698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89816982022-04-06 Propranolol as therapy for cerebral cavernous malformations: a cautionary note Shenkar, Robert Moore, Thomas Benavides, Christian Lightle, Rhonda Detter, Matthew R. Hobson, Nicholas Girard, Romuald DeBiasse, Dorothy Patrucco, Mary Gallione, Carol Zabramski, Joseph M. Marchuk, Douglas A. Awad, Issam A. J Transl Med Letter to the Editor BioMed Central 2022-04-05 /pmc/articles/PMC8981698/ /pubmed/35382850 http://dx.doi.org/10.1186/s12967-022-03360-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Shenkar, Robert Moore, Thomas Benavides, Christian Lightle, Rhonda Detter, Matthew R. Hobson, Nicholas Girard, Romuald DeBiasse, Dorothy Patrucco, Mary Gallione, Carol Zabramski, Joseph M. Marchuk, Douglas A. Awad, Issam A. Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title | Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title_full | Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title_fullStr | Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title_full_unstemmed | Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title_short | Propranolol as therapy for cerebral cavernous malformations: a cautionary note |
title_sort | propranolol as therapy for cerebral cavernous malformations: a cautionary note |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981698/ https://www.ncbi.nlm.nih.gov/pubmed/35382850 http://dx.doi.org/10.1186/s12967-022-03360-4 |
work_keys_str_mv | AT shenkarrobert propranololastherapyforcerebralcavernousmalformationsacautionarynote AT moorethomas propranololastherapyforcerebralcavernousmalformationsacautionarynote AT benavideschristian propranololastherapyforcerebralcavernousmalformationsacautionarynote AT lightlerhonda propranololastherapyforcerebralcavernousmalformationsacautionarynote AT dettermatthewr propranololastherapyforcerebralcavernousmalformationsacautionarynote AT hobsonnicholas propranololastherapyforcerebralcavernousmalformationsacautionarynote AT girardromuald propranololastherapyforcerebralcavernousmalformationsacautionarynote AT debiassedorothy propranololastherapyforcerebralcavernousmalformationsacautionarynote AT patruccomary propranololastherapyforcerebralcavernousmalformationsacautionarynote AT gallionecarol propranololastherapyforcerebralcavernousmalformationsacautionarynote AT zabramskijosephm propranololastherapyforcerebralcavernousmalformationsacautionarynote AT marchukdouglasa propranololastherapyforcerebralcavernousmalformationsacautionarynote AT awadissama propranololastherapyforcerebralcavernousmalformationsacautionarynote |